Advertisement!
18.232.56.9
For Authors
Editorial Board
Submit article
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Articles
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
Subscribe
FAQ
Contact Us
Pediatrics Education and Research

Volume  5, Issue 2, May-Aug 2017, Pages 57-60

 

Original Article

A Retrospective Study of Intrathechal vs. Intramuscular Administration of Human Tetanus Immunoglobulin in Pediatric Tetanus
Minesh L. Bhikadiya*, Jayendra R. Gohil**, Bhoomika R. Patel*, Alpa N. Parekh***, Mehul M. Gosai***
*Resident **Professor ***Associate Professor, Department of Pediatrics, Govt. Medical College, Sir T. Hospital, Bhavnagar364002, Gujarat, India.
Choose an option to locate / access this Article:
Check if you have access through your login credentials.             |
|

DOI: https://dx.doi.org/10.21088/per.2321.1644.5217.11

Abstract

Aim: To evaluate the effect of intrathecal vs. intramuscular tetanus immunoglobulin therapy on hospital stay and mortality in pediatric tetanus patients admitted to a tertiary care hospital. Methods and Material: Retrospective analysis of hospital records of tetanus cases to the pediatric ward during two year period between 2012 and 2014 was done. All patients were managed as per preexisting unit protocol. Group A received Human tetanus immunoglobulin (TIG) 250 unit a via the Intrathecal route preceded by IV ketamine (1 mg/kg) for proper relaxation to ease the procedure and the group B was given TIG 750 unit via intramuscular route. Whether to give TIG by Intrathecal or intramuscular route was decided according to the treating unit’s protocol. Information regarding sex, age, immunization status, mode of infection, grade of tetanus, outcome and hospital stay was recorded in the two groups. Statistical Analysis: Fisher’s exact test, Chi square test, Unpaired t test. Results: There were total 40 patients with tetanus aged between 1 to 12 years during the two year study period. Neonatal tetanus cases were excluded. Out of 40, 15 patients were included in group A (intrathecal route) and 25 in group B (intramuscular route). Mortality and hospital stay was found to be less in group A (26.67%; 12.4 ±2.25days) as compared to group B (28%:15.4 ± 1.69 days). Conclusion: We found no significant difference between intrathecal immunoglobulin and intramuscular immunoglobulin therapy in management of pediatric tetanus in terms of mortality and hospital stay.

Keywords: Tetanus; Immunoglobulin; Intrathecal. 


Corresponding Author : Jayendra R. Gohil, Professor, Department of Pediatrics, Govt. Medical College, Sir T. Hospital, Bhavnagar364002, Gujarat, India.